Zoletil 100 (50 mg/ml+50 mg/ml) Lyophilisate and Solvent for Solution for Injection for Dogs and Cats

Kraj: Wielka Brytania

Język: angielski

Źródło: VMD (Veterinary Medicines Directorate)

Kup teraz

Składnik aktywny:

Tiletamine, Zolazepam

Dostępny od:

Virbac

Kod ATC:

QN01AX99

INN (International Nazwa):

Tiletamine, Zolazepam

Forma farmaceutyczna:

Lyophilisate and solvent for solution for injection

Typ recepty:

POM-V - Prescription Only Medicine – Veterinarian

Grupa terapeutyczna:

Cats, Dogs

Dziedzina terapeutyczna:

Neurological Agent general anaesthetic

Status autoryzacji:

Authorized

Data autoryzacji:

2016-04-20

Charakterystyka produktu

                                Revised: April 2023
AN: 00777/2022 & 00782/2022
Page 1 of 7
SUMMARY OF PRODUCT CHARACTERISTICS
1.
NAME OF THE VETERINARY MEDICINAL PRODUCT
ZOLETIL 100 (50 mg/ml+50 mg/ml) Lyophilisate and Solvent for Solution
for Injection
for Dogs and Cats
2.
QUALITATIVE AND QUANTITATIVE COMPOSITION
Each vial of 970 mg lyophilisate contains:
Active substances:
Tiletamine (as hydrochloride)
250.00 mg
Zolazepam (as hydrochloride)
250.00 mg
Each vial of 5 ml solvent contains:
Benzyl alcohol (E1519)
0.100 g
Water for injections
5.00 ml
Each ml of reconstituted solution contains:
Active substances:
Tiletamine (as hydrochloride)
50.00 mg
Zolazepam (as hydrochloride)
50.00 mg
Excipient:
Benzyl alcohol (E1519)
20.00 mg
For the full list of excipients, see section 6.1.
3.
PHARMACEUTICAL FORM
Lyophilisate and solvent for solution for injection.
Appearance of the lyophilisate: White to slightly yellow compact mass;
Appearance of the solvent: Clear colourless liquid;
Appearance of the reconstituted solution: Clear, colourless to
slightly green-yellow
solution, free from particles.
4.
CLINICAL PARTICULARS
4.1
TARGET SPECIES
Dogs and cats.
4.2
INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
General anaesthesia.
Revised: April 2023
AN: 00777/2022 & 00782/2022
Page 2 of 7
4.3
CONTRAINDICATIONS
Do not use in cases of hypersensitivity to the active substances or to
any of the
excipients.
Do not use in animals with severe cardiac or respiratory disease, or
in animals with
renal, pancreatic or hepatic insufficiency.
Do not use in the event of severe hypertension.
Do not use in rabbits.
Do not use in animals with head trauma or intracranial tumours.
Do not use for caesarean section.
Do not use in pregnant bitches and queens.
4.4
SPECIAL WARNINGS FOR EACH TARGET SPECIES
In dogs, since zolazepam is eliminated more quickly than tiletamine,
there is a shorter
duration of tranquilisation than there is of anaesthesia.
4.5
SPECIAL PRECAUTIONS FOR USE
i) Special precautions for use in animals
Animals should be fasted for 12 hours prior to anaesthesia.
Re
                                
                                Przeczytaj cały dokument
                                
                            

Wyszukaj powiadomienia związane z tym produktem